SIWA Therapeutics is Biotechnology in United States that focus on monoclonal antibody business. Founded in 2011. They cover business area such as operator, emphasis, cancerous cell, class, [dq]mAb, both senescent cell, [dq]sc, cancer cell, destruction, vivo result, normally-aged, very old mouse, cancer metastasis lung foci, triple-negative breast cancer model, environment.
2011
( 13 years old in 2024 )
Monoclonal Antibody
-
400 East Randolph Street
Suite 705
Chicago, IL 60601
United States
Private
operatoremphasiscancerous cellclass[dq]mAbboth senescent cell[dq]sccancer celldestructionvivo resultnormally-aged, very old mousecancer metastasis lung focitriple-negative breast cancer modelenvironment
* We use standard office opening hours in near SIWA Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SIWA Therapeutics is Biotechnology business from United States that founded in 2011 (13 years old in 2024), SIWA Therapeutics business is focusing on Monoclonal Antibody.
SIWA Therapeutics headquarter office and corporate office address is located in 400 East Randolph Street Suite 705 Chicago, IL 60601 United States.
SIWA Therapeutics was founded in United States.
In 2024, SIWA Therapeutics is currently focus on monoclonal antibody sector.
Above is snippet of Google Trends for "monoclonal antibody" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SIWA Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
